RxDoctor Payments Data

Christopher Nicholas, MD

Thoracic Surgery (Cardiothoracic Vascular Surgery) · West Burlington, IANPI 1316037195

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 9 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 6 manufacturers reported payments, led by AbbVie at 30.2% of the total. Reporting peaked in 2019 at $69 and has fallen 66.2% since, to $23 in 2025. That places this record below the midpoint for thoracic surgery (cardiothoracic vascular surgery) clinicians in IA, where the typical reported total is $2,703.

$174in general payments, 2019–2025

Across 9 payments — averaging $19.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$53
  • Misonix Inc$37
  • Medtronic$36
  • Leica Microsystems Inc.$19
  • Johnson & Johnson$16
  • Braintree Laboratories, Inc.$14

What the payments were for

  • Food & beverage$174100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$174 in reported general payments places this provider in the 15th percentile of 48 thoracic surgery (cardiothoracic vascular surgery) providers in Iowa.

See all thoracic surgery (cardiothoracic vascular surgery) providers in Iowa

Medicare billing

Part B allowed, 2024
$172,915
Medicare patients
541
Services billed
1,429

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates167$10,379
Sucralfate107$4,385
Famotidine288$3,193
Pantoprazole Sodium71$701
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen55$567
Gavilyte-GPeg3350/Sod Sulf,bicarb,cl/Kcl34$481
Peg-3350 And ElectrolytesPeg3350/Sod Sulf,bicarb,cl/Kcl12$217
Lactulose28$115
Omeprazole16$95
Metronidazole11$66

Paid to pharmacies, not to this prescriber.

Other thoracic surgery (cardiothoracic vascular surgery) in West Burlington

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →